MICHAEL NERET: Open Payments
NPI 1306827951 · BAY CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 27 payments from 11 companies in 2025. Trend: 2023 $529 · 2024 $815 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $270 |
| Lilly USA, LLC | 8 | $130 |
| ABBVIE INC. | 3 | $90 |
| Astellas Pharma US Inc | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Antares Pharma, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: FARXIGA, MOUNJARO, UBRELVY, JARDIANCE, Veozah, Kerendia, QULIPTA, XYOSTED.
Industry payments across TX — which companies pay providers there.
